Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway.

Silvestre, J S

Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway. [electronic resource] - Circulation research Oct 2001 - 678-83 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1524-4571

10.1161/hh2001.097691 doi


Angiotensin-Converting Enzyme Inhibitors--pharmacology
Animals
Antihypertensive Agents--pharmacology
Blood Flow Velocity--drug effects
Blood Pressure--drug effects
Capillaries--drug effects
Cell Count
Cyclic GMP--metabolism
Disease Models, Animal
Endothelial Growth Factors--metabolism
Femoral Artery--physiopathology
Hindlimb--blood supply
Ischemia--physiopathology
Lymphokines--metabolism
Male
Mice
Mice, Knockout
Neovascularization, Physiologic--drug effects
Nitric Oxide--metabolism
Nitric Oxide Synthase--metabolism
Nitric Oxide Synthase Type II
Nitric Oxide Synthase Type III
Receptor, Bradykinin B2
Receptors, Bradykinin--deficiency
Signal Transduction--drug effects
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors